Loading…

Interleukin-6 is present in early stages of plaque formation and is restricted to the brains of Alzheimer's disease patients

Interleukin-6 (IL-6) immunoreactivity has previously been shown in plaques in Alzheimer's disease (AD) and elevated IL-6 concentrations have been measured biochemically in brains of AD patients. In this study, we investigated the appearance of IL-6 immunoreactivity in AD plaques according to th...

Full description

Saved in:
Bibliographic Details
Published in:Acta neuropathologica 1995, Vol.89 (6), p.544-551
Main Authors: HUELL, M, STRAUSS, S, VOLK, B, BERGER, M, BAUER, J
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c383t-565b729eaaba1b5f9ee12b0c4362d7b654439e552dec224b266a23810755f2513
cites cdi_FETCH-LOGICAL-c383t-565b729eaaba1b5f9ee12b0c4362d7b654439e552dec224b266a23810755f2513
container_end_page 551
container_issue 6
container_start_page 544
container_title Acta neuropathologica
container_volume 89
creator HUELL, M
STRAUSS, S
VOLK, B
BERGER, M
BAUER, J
description Interleukin-6 (IL-6) immunoreactivity has previously been shown in plaques in Alzheimer's disease (AD) and elevated IL-6 concentrations have been measured biochemically in brains of AD patients. In this study, we investigated the appearance of IL-6 immunoreactivity in AD plaques according to the stage of plaque formation. Using the Bielschowsky silver-staining method, we were able to differentiate between four types of plaques described earlier: diffuse, primitive, classic and compact. While diffuse plaques represent the early stage of plaque formation, primitive and classic plaques are thought to represent later stages of plaque development. We investigated serial sections of paraffin-embedded cortices of ten clinically diagnosed and histopathologically confirmed AD patients and ten patients with no clinical history of dementia. We found plaques in the brains of both nondemented and demented persons using the silver staining method or immunohistochemistry with antibodies against the amyloid precursor protein. In the group of clinically nondemented persons, diffuse plaques were the predominant plaque type, whereas primitive plaques formed the larger portion of lesions in the group of AD brains. IL-6 could not be detected in plaques of patients without dementia. Many IL-6-positive plaques were found in six of the AD brains and to a smaller extent in the other four AD cases. In the six cases with a large number of IL-6-positive plaques, IL-6 was found in a significantly higher ratio of diffuse plaques than expected from a random distribution of IL-6 in all plaque types.
doi_str_mv 10.1007/BF00571510
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_77536378</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>16851698</sourcerecordid><originalsourceid>FETCH-LOGICAL-c383t-565b729eaaba1b5f9ee12b0c4362d7b654439e552dec224b266a23810755f2513</originalsourceid><addsrcrecordid>eNqFkc1P20AQxVcVVQiBS-9Ie0AgVTLdD-9ufAQELVKkXujZGtvjZou9NjubQ1D_eJwSpUdOo9H83hs9Pca-SHEthXDfbh-EME4aKT6xucy1yoTR-ojNhRAys1qpY3ZC9GfalMvNjM2cdXYpxZz9fQwJY4ebZx8yyz3xMSJhSNwHjhC7LacEv5H40PKxg5cN8naIPSQ_BA6h2UkmRYq-TtjwNPC0Rl5F8OGf5qZ7XaPvMV4RbzwhEPJxUk8v6JR9bqEjPNvPBfv1cP909yNb_fz-eHezymq91Ckz1lROFQhQgaxMWyBKVYk611Y1rrImz3WBxqgGa6XySlkLSk_xnDGtMlIv2OW77xiHKQClsvdUY9dBwGFDpXNGW-2WH4LSLo20xQ78-g7WcSCK2JZj9D3EbSlFueuk_N_JBJ_vXTdVj80B3Zcw3S_2d6AaujZCqD0dMG20LAqr3wACsZMp</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>16851698</pqid></control><display><type>article</type><title>Interleukin-6 is present in early stages of plaque formation and is restricted to the brains of Alzheimer's disease patients</title><source>Springer Online Journals Archive Complete</source><creator>HUELL, M ; STRAUSS, S ; VOLK, B ; BERGER, M ; BAUER, J</creator><creatorcontrib>HUELL, M ; STRAUSS, S ; VOLK, B ; BERGER, M ; BAUER, J</creatorcontrib><description>Interleukin-6 (IL-6) immunoreactivity has previously been shown in plaques in Alzheimer's disease (AD) and elevated IL-6 concentrations have been measured biochemically in brains of AD patients. In this study, we investigated the appearance of IL-6 immunoreactivity in AD plaques according to the stage of plaque formation. Using the Bielschowsky silver-staining method, we were able to differentiate between four types of plaques described earlier: diffuse, primitive, classic and compact. While diffuse plaques represent the early stage of plaque formation, primitive and classic plaques are thought to represent later stages of plaque development. We investigated serial sections of paraffin-embedded cortices of ten clinically diagnosed and histopathologically confirmed AD patients and ten patients with no clinical history of dementia. We found plaques in the brains of both nondemented and demented persons using the silver staining method or immunohistochemistry with antibodies against the amyloid precursor protein. In the group of clinically nondemented persons, diffuse plaques were the predominant plaque type, whereas primitive plaques formed the larger portion of lesions in the group of AD brains. IL-6 could not be detected in plaques of patients without dementia. Many IL-6-positive plaques were found in six of the AD brains and to a smaller extent in the other four AD cases. In the six cases with a large number of IL-6-positive plaques, IL-6 was found in a significantly higher ratio of diffuse plaques than expected from a random distribution of IL-6 in all plaque types.</description><identifier>ISSN: 0001-6322</identifier><identifier>EISSN: 1432-0533</identifier><identifier>DOI: 10.1007/BF00571510</identifier><identifier>PMID: 7676810</identifier><identifier>CODEN: ANPTAL</identifier><language>eng</language><publisher>Berlin: Springer</publisher><subject>Aged ; Aged, 80 and over ; Alzheimer Disease - metabolism ; Alzheimer Disease - pathology ; Biological and medical sciences ; Brain - pathology ; Brain Chemistry ; Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases ; Humans ; Immunohistochemistry ; Interleukin-6 - metabolism ; Medical sciences ; Middle Aged ; Neurology ; Silver Staining</subject><ispartof>Acta neuropathologica, 1995, Vol.89 (6), p.544-551</ispartof><rights>1995 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c383t-565b729eaaba1b5f9ee12b0c4362d7b654439e552dec224b266a23810755f2513</citedby><cites>FETCH-LOGICAL-c383t-565b729eaaba1b5f9ee12b0c4362d7b654439e552dec224b266a23810755f2513</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,4010,27900,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=3531996$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/7676810$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>HUELL, M</creatorcontrib><creatorcontrib>STRAUSS, S</creatorcontrib><creatorcontrib>VOLK, B</creatorcontrib><creatorcontrib>BERGER, M</creatorcontrib><creatorcontrib>BAUER, J</creatorcontrib><title>Interleukin-6 is present in early stages of plaque formation and is restricted to the brains of Alzheimer's disease patients</title><title>Acta neuropathologica</title><addtitle>Acta Neuropathol</addtitle><description>Interleukin-6 (IL-6) immunoreactivity has previously been shown in plaques in Alzheimer's disease (AD) and elevated IL-6 concentrations have been measured biochemically in brains of AD patients. In this study, we investigated the appearance of IL-6 immunoreactivity in AD plaques according to the stage of plaque formation. Using the Bielschowsky silver-staining method, we were able to differentiate between four types of plaques described earlier: diffuse, primitive, classic and compact. While diffuse plaques represent the early stage of plaque formation, primitive and classic plaques are thought to represent later stages of plaque development. We investigated serial sections of paraffin-embedded cortices of ten clinically diagnosed and histopathologically confirmed AD patients and ten patients with no clinical history of dementia. We found plaques in the brains of both nondemented and demented persons using the silver staining method or immunohistochemistry with antibodies against the amyloid precursor protein. In the group of clinically nondemented persons, diffuse plaques were the predominant plaque type, whereas primitive plaques formed the larger portion of lesions in the group of AD brains. IL-6 could not be detected in plaques of patients without dementia. Many IL-6-positive plaques were found in six of the AD brains and to a smaller extent in the other four AD cases. In the six cases with a large number of IL-6-positive plaques, IL-6 was found in a significantly higher ratio of diffuse plaques than expected from a random distribution of IL-6 in all plaque types.</description><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Alzheimer Disease - metabolism</subject><subject>Alzheimer Disease - pathology</subject><subject>Biological and medical sciences</subject><subject>Brain - pathology</subject><subject>Brain Chemistry</subject><subject>Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases</subject><subject>Humans</subject><subject>Immunohistochemistry</subject><subject>Interleukin-6 - metabolism</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Neurology</subject><subject>Silver Staining</subject><issn>0001-6322</issn><issn>1432-0533</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1995</creationdate><recordtype>article</recordtype><recordid>eNqFkc1P20AQxVcVVQiBS-9Ie0AgVTLdD-9ufAQELVKkXujZGtvjZou9NjubQ1D_eJwSpUdOo9H83hs9Pca-SHEthXDfbh-EME4aKT6xucy1yoTR-ojNhRAys1qpY3ZC9GfalMvNjM2cdXYpxZz9fQwJY4ebZx8yyz3xMSJhSNwHjhC7LacEv5H40PKxg5cN8naIPSQ_BA6h2UkmRYq-TtjwNPC0Rl5F8OGf5qZ7XaPvMV4RbzwhEPJxUk8v6JR9bqEjPNvPBfv1cP909yNb_fz-eHezymq91Ckz1lROFQhQgaxMWyBKVYk611Y1rrImz3WBxqgGa6XySlkLSk_xnDGtMlIv2OW77xiHKQClsvdUY9dBwGFDpXNGW-2WH4LSLo20xQ78-g7WcSCK2JZj9D3EbSlFueuk_N_JBJ_vXTdVj80B3Zcw3S_2d6AaujZCqD0dMG20LAqr3wACsZMp</recordid><startdate>1995</startdate><enddate>1995</enddate><creator>HUELL, M</creator><creator>STRAUSS, S</creator><creator>VOLK, B</creator><creator>BERGER, M</creator><creator>BAUER, J</creator><general>Springer</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>7X8</scope></search><sort><creationdate>1995</creationdate><title>Interleukin-6 is present in early stages of plaque formation and is restricted to the brains of Alzheimer's disease patients</title><author>HUELL, M ; STRAUSS, S ; VOLK, B ; BERGER, M ; BAUER, J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c383t-565b729eaaba1b5f9ee12b0c4362d7b654439e552dec224b266a23810755f2513</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1995</creationdate><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Alzheimer Disease - metabolism</topic><topic>Alzheimer Disease - pathology</topic><topic>Biological and medical sciences</topic><topic>Brain - pathology</topic><topic>Brain Chemistry</topic><topic>Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases</topic><topic>Humans</topic><topic>Immunohistochemistry</topic><topic>Interleukin-6 - metabolism</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Neurology</topic><topic>Silver Staining</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>HUELL, M</creatorcontrib><creatorcontrib>STRAUSS, S</creatorcontrib><creatorcontrib>VOLK, B</creatorcontrib><creatorcontrib>BERGER, M</creatorcontrib><creatorcontrib>BAUER, J</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Acta neuropathologica</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>HUELL, M</au><au>STRAUSS, S</au><au>VOLK, B</au><au>BERGER, M</au><au>BAUER, J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Interleukin-6 is present in early stages of plaque formation and is restricted to the brains of Alzheimer's disease patients</atitle><jtitle>Acta neuropathologica</jtitle><addtitle>Acta Neuropathol</addtitle><date>1995</date><risdate>1995</risdate><volume>89</volume><issue>6</issue><spage>544</spage><epage>551</epage><pages>544-551</pages><issn>0001-6322</issn><eissn>1432-0533</eissn><coden>ANPTAL</coden><abstract>Interleukin-6 (IL-6) immunoreactivity has previously been shown in plaques in Alzheimer's disease (AD) and elevated IL-6 concentrations have been measured biochemically in brains of AD patients. In this study, we investigated the appearance of IL-6 immunoreactivity in AD plaques according to the stage of plaque formation. Using the Bielschowsky silver-staining method, we were able to differentiate between four types of plaques described earlier: diffuse, primitive, classic and compact. While diffuse plaques represent the early stage of plaque formation, primitive and classic plaques are thought to represent later stages of plaque development. We investigated serial sections of paraffin-embedded cortices of ten clinically diagnosed and histopathologically confirmed AD patients and ten patients with no clinical history of dementia. We found plaques in the brains of both nondemented and demented persons using the silver staining method or immunohistochemistry with antibodies against the amyloid precursor protein. In the group of clinically nondemented persons, diffuse plaques were the predominant plaque type, whereas primitive plaques formed the larger portion of lesions in the group of AD brains. IL-6 could not be detected in plaques of patients without dementia. Many IL-6-positive plaques were found in six of the AD brains and to a smaller extent in the other four AD cases. In the six cases with a large number of IL-6-positive plaques, IL-6 was found in a significantly higher ratio of diffuse plaques than expected from a random distribution of IL-6 in all plaque types.</abstract><cop>Berlin</cop><pub>Springer</pub><pmid>7676810</pmid><doi>10.1007/BF00571510</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0001-6322
ispartof Acta neuropathologica, 1995, Vol.89 (6), p.544-551
issn 0001-6322
1432-0533
language eng
recordid cdi_proquest_miscellaneous_77536378
source Springer Online Journals Archive Complete
subjects Aged
Aged, 80 and over
Alzheimer Disease - metabolism
Alzheimer Disease - pathology
Biological and medical sciences
Brain - pathology
Brain Chemistry
Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases
Humans
Immunohistochemistry
Interleukin-6 - metabolism
Medical sciences
Middle Aged
Neurology
Silver Staining
title Interleukin-6 is present in early stages of plaque formation and is restricted to the brains of Alzheimer's disease patients
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T00%3A47%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Interleukin-6%20is%20present%20in%20early%20stages%20of%20plaque%20formation%20and%20is%20restricted%20to%20the%20brains%20of%20Alzheimer's%20disease%20patients&rft.jtitle=Acta%20neuropathologica&rft.au=HUELL,%20M&rft.date=1995&rft.volume=89&rft.issue=6&rft.spage=544&rft.epage=551&rft.pages=544-551&rft.issn=0001-6322&rft.eissn=1432-0533&rft.coden=ANPTAL&rft_id=info:doi/10.1007/BF00571510&rft_dat=%3Cproquest_cross%3E16851698%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c383t-565b729eaaba1b5f9ee12b0c4362d7b654439e552dec224b266a23810755f2513%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=16851698&rft_id=info:pmid/7676810&rfr_iscdi=true